Richmond Pharmacology is excited to join the AHA Hypertension Scientific Sessions 2026 in Arlington, USA, on 07 – 11  October 2026.

Uniting global experts in hypertension research and cardiovascular health, this meeting serves as a platform for groundbreaking science, clinical insights, and collaborative strategies to improve patient outcomes worldwide.

Representing Richmond Pharmacology

  • Jörg Taubel, Chief Executive Officer

We look forward to connecting with attendees to discuss Richmond’s expertise in:

  • Innovations in hypertension drug development
  • Clinical trial design for complex cardiovascular conditions
  • Regulatory pathways for novel therapies
  • Patient-centric approaches and recruitment strategies
  • Collaboration between academia, industry, and regulators

Connect With Us

If you are attending AHA Hypertension Scientific Sessions 2026 and would like to explore partnership or development opportunities email us at:

📧 fasteranswers@richmondpharmacology.com

‍

Latest news

Leadership Spotlight - Head of Pharmacovigilance

November 16, 2026
Amina Ghareeb on Building Richmond's Pharmacovigilance Expertise
Read more

Upcoming Event

JSCPT 2026

27 - 28 November 2026
Richmond Pharmacology is excited to join the JSCPT Annual Meeting 2026 in Tokyo, Japan, on 27-28 November 2026.
View event